Evaluation of the in vitro differential protein adsorption patterns of didanosine-loaded nanostructured lipid carriers (NLCs) for potential targeting to the brain

References

• Bio-Rad Laboratories. (2010). Bio-Rad silver staining. http://www.biorad.com/webroot/web/pdf/lsr/literature/Bulletin_9057.pdf. Last accessed September 2, 2010. Munich, Germany: Bio-Rad Laboratories.
   Google Scholar
• Allen, T. M., Moase, E. H. (1996). Therapeutic opportunities for targeted liposomal drug delivery. Adv Drug Deliv Rev 21:117–133.
   Web of Science ®Google Scholar
• Altieri, D. C., Mannucci, P. N., Capitanio, A. M. (1986). Binding of fibrinogen to human monocytes. J Clin Invest 78:968–976.
   PubMed Web of Science ®Google Scholar
• Alyautdin, R. N., Petrov, V. E., Langer, K., Berthold, A., Kharkevich, D. A., Kreuter, J. (1997). Delivery of loperamide across the blood-brain barrier with polysorbate 80–coated polybutylcyanoacrylate nanoparticles. Pharmaceut Res 14:325–328.
   PubMed Web of Science ®Google Scholar
• Alyautdin, R. N., Tezikov, E. B., Ramge, P., Kharkevich, D. A., Begley, D. J., Kreuter, J. (1998). Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80–coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study. J Microencapsul 15:67–74.
   PubMed Web of Science ®Google Scholar
• Archambault, J. G., Brash, J. L. (2004). Protein-resistant polyurethane surfaces by chemical grafting of PEO: amino-terminated PEO as grafting reagent. Coll Surf B 39(1–2):9–16.
   PubMedGoogle Scholar
• Blunk, T., Hochstrasser, D. F., Sanchez, J. C., Müller, B. W., Müller, R. H. (1993). Colloidal carriers for intravenous targeting: plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 14:1382–1387.
   PubMed Web of Science ®Google Scholar
• Camner, P., Lundborg, M., Lastbom, L., Gerde, P., Gross, N., Jarstrand, C. (2002). Experimental and calculated parameters on particle phagocytosis by alveolar macrophages. J Appl Physiol 92:2608–2616.
   PubMed Web of Science ®Google Scholar
• Celis, J. E., Trentemolle, S., Gromov, P. (2006). Gel-based proteomics: high-resolution two-dimensional gel electrophoresis of proteins: isolectric focusing (IEF) and nonequilibrium pH gradient electrophoresis (NEPHGE), 3rd ed. San Diego, California, USA: Academic Press.
   Google Scholar
• Cornelius, R. M.., Sanchez, J., Olsson, P., Brash, J. L. (2003). Interactions of antithrombin and proteins in the plasma contact activation system with immobilized functional heparin. J Biomed Mater Res 67:475–483.
   Google Scholar
• D’Souza, M. J., DeSouza, P. (1995). Site-specific microencapsulated drug targeting strategies— liver and gastrointestinal tract targeting. Adv Drug Deliv Rev 17:247–254.
   Web of Science ®Google Scholar
• Douglas, S. J., Davis, S. S., Illum, L. (1986). Biodistribution of poly(isobutyl-cyanoacrylate) nanoparticles in rabbits. Int J Pharma 34:145–152.
   Web of Science ®Google Scholar
• Edlund, U., Albertsson, A. C., Singh, S. K., Fogelberg, I., Lundgren, B. O. (2000). Sterilization, storage stability, and in vivo biocompatibility of poly(trimethylenecarbonate)/poly(adipic anhydride) blends. Biomaterials 21:945–955.
   PubMedGoogle Scholar
• Elwing, H. (1998). Protein absorption and ellipsometry in biomaterial research. Biomaterials 19(4–5):397–406.
   PubMedGoogle Scholar
• Gessner, A., Olbrich, C., Schröder, W., Kayser, O., Müller, R. H. (2001). The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles. Int J Pharm 214(1–2):87–91.
   PubMedGoogle Scholar
• Göppert, T. M., Müller, R. H. (2005a). Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting. Int J Pharm 302(1–2):172–186.
   PubMedGoogle Scholar
• Göppert, T. M., Müller, R. H. (2005b). Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns. J Drug Targ 13:179–187.
   PubMed Web of Science ®Google Scholar
• Göppert, T. M., Müller, R. H. (2005c). Protein adsorption patterns on poloxamer and poloxamine-stabilized solid lipid nanoparticles. Eur J Pharm Biopharm 60:361–372.
   PubMed Web of Science ®Google Scholar
• Göpper, T. M., Müller, R. H. (2003). Plasma protein adsorption of Tween 80 and poloxamer 188–stabilized solid lipid nanoparticles. J Drug Target, 11:225–231.
   PubMed Web of Science ®Google Scholar
• Gulyaev, A. E., Gelperina, S. E., Skidan, A. S., Antropov, G. Y., Kreuter, J. (1999). Significant transport of doxurubicin into the brain with polysorbate 80–coated nanoparticles. Pharm Res 16:1564–1569.
   PubMed Web of Science ®Google Scholar
• Harnisch, S., Müller, R. H. (1998). Plasma protein adsorption patterns on emulsions for parenteral administration: establishment of a protocol for two-dimensional polyacrylamide electrophoresis. Electrophoresis 19:349–354.
   PubMedGoogle Scholar
• Illum, S. L., Davis, S. S. (1983). Effect of the nonionic surfactant, poloxamer 338, on the fate and deposition of polystyrene microspheres following intravenous administration. J Pharm Sci 72:1086–1089.
   PubMed Web of Science ®Google Scholar
• Kazatchkine, M. D., Carreno, M. P. (1988). Activation of the complement system at the interface between blood and artificial surfaces. Biomaterials 9:30–35.
   PubMed Web of Science ®Google Scholar
• Kreuter, J. (2001). Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 47:65–81.
   PubMed Web of Science ®Google Scholar
• Kreuter, J., Alyautdin, R. N., Kharkevich, D. A., Ivanov, A. A. (1995). Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Res 674:171–174.
   PubMed Web of Science ®Google Scholar
• Kreuter, J., Ramge, P., Petrov, V., Hamm, S., Gelperina, S. E., Engelhardt, B., et al. (2003a). Direct evidence that polysorbate-80–coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles. Pharm Res 20:409–416.
   PubMed Web of Science ®Google Scholar
• Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., et al. (2003b). Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Targ 10:317–325.
   Google Scholar
• Leroux, J. C., De Jaeghere, F., Anner, B., Doelker, E., Gurny, R. (1995). An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(DL-lactic acid) nanoparticles by human monocytes. Life Sci 57:695–703.
   PubMed Web of Science ®Google Scholar
• Li, J. T., Caldwell, K. D. (1996). Plasma protein interactions with PluronicTM-treated colloids. Coll Surf B 7(1–2):9–22.
   Web of Science ®Google Scholar
• Mehnert, W., Mäder, K. (2001). Solid lipid nanoparticles: production, characterization, and applications. Adv Drug Deliv Rev 47(2–3):165–196.
   PubMed Web of Science ®Google Scholar
• Moghimi, S. M., Muir, I. S., Illum, L., Davis, S. S., Kolb-Bachofen, V. (1993). Coating particles with a block copolymer (poloxamine 908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochim Biophys Acta 1179:157–165.
   Google Scholar
• Müller, R. H., Mäder, K., Gohla, S. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art. Eur J Pharm Biopharm 50:161–177.
   PubMed Web of Science ®Google Scholar
• Müller, R. H., Radtke, M., Wissing, S. A. (2002). Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 242(1–2):121–128.
   PubMedGoogle Scholar
• Müller, R. H., Heinemann, S. (1989). Surface modelling of microspheres as paranteral systems with high tissue affinity. In: Gurny, R., Junginger, H. E. (Eds.), Bioadhesion: possibilities and future trends ( pp 202–214). Stuttgart, Germany: Wissenschaftliche Verlagsgesellschaft GmbH.
   Google Scholar
• Ogawara, K., Furumoto, K. F., Nagayama, S., Minato, K., Higaki, K., Kai, T., et al. (2004). Precoating with serum albumin reduces receptor-mediated hepatic disposition of polystyrene nanosphere: implications for rational design of nanoparticles. J Contr Rel 100:451–455.
   PubMed Web of Science ®Google Scholar
• Oleschuk, R. D., McComb, M. E., Chow, A., Ens, W., Standing, K. G., Perreault, H., et al. (2000). Characterization of plasma proteins adsorbed onto biomaterials by MALDI-TOFMS. Biomaterials 21:1701–1710.
   PubMedGoogle Scholar
• Pal Kaur, I., Bhandari, R., Bhandari, S., Kakkar, V. (2007). Potential of solid lipid nanoparticles in brain targeting. J Contr Rel 127:97–109.
   Web of Science ®Google Scholar
• Patel, H. M. (1992). Serum opsonins and liposomes: their interaction and opsonophagocytosis. Crit Rev Ther Drug 9:39–90.
   PubMed Web of Science ®Google Scholar
• Pommier, C. G., O’Shea, J., Chused, T., Takahashi, T., Ochoa, M., Nutman, T. B., et al. (1984). Differentiation stimuli induce receptors for plasma fibronectin on the human myelomonocytic cell line, HL-60. Blood 64:858–866.
   PubMedGoogle Scholar
• Portegies, P. (1994). AIDS dementia complex: a review. J Acq Imm Def Synd 7:S38–S49
   PubMed Web of Science ®Google Scholar
• Radtke, M., Souto, E. B., Müller, R. H. (2005). Nanostructured lipid carriers: a novel generation of solid lipid drug carriers. Pharm Tech Eur 17:45–50.
   Google Scholar
• Saez, A., Guzman, M., Molpeceres, J., Aberturas, M. R. (2000). Freeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs. Eur J Pharm Biopharm 50:379–387.
   PubMed Web of Science ®Google Scholar
• Schrager, L. K., D’Souza, M. P. (1998). Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy. J Am Med Assoc 280:67–71.
   PubMed Web of Science ®Google Scholar
• Storm, G., Belliot, S., Daemen, T., Lasic, D. (1995). Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv Drug Deliv Rev 17:31–48.
   Web of Science ®Google Scholar
• Tabana, Y., Ikada, Y. (1988). Effect of size and surface charge of polymer microspheres on their phagocytosis by macrophages. Biomaterials 9:356–362.
   PubMedGoogle Scholar
• Van Leuven, F., Marynen, P., Sottrup-Jensen, L., Cassiman, J. J., van den Berghe, H. (1986). The receptor-binding domain of human alpha 2-macroglobulin. Isolation after limited proteolysis with a bacterial proteinase. J Biol Chem 261:11369–11373.
   PubMedGoogle Scholar
• Vogel, W., Bomford, A., Young, S., Williams, R. (1987). Heterogeneous distribution of transferrin receptors on parenchymal and nonparenchymal liver cells: biochemical and morphological evidence. Blood 69:264–270.
   PubMed Web of Science ®Google Scholar
• Weisgraber, K. H., Mahley, R. W., Kowal, R. C., Herz, J., Goldstein, J. L., Brown, M. S. (1990). Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein. J Biol Chem 65:22453–22459.
   Google Scholar
• Westesen, K., Bunjes, H., and Koch, M. H. J. (1997). Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J Contr Rel 48(2–3):223–236.
   Google Scholar
• Westesen, K., Siekmann, B. (1997). Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles. Int J Pharm 151:35–45.
   Web of Science ®Google Scholar
• Wilson, B., Samanta, M. K., Santhi, K., Kumar, K. P. S., Paramakrishnan, N., Suresh, B. (2008). Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer’s disease. Brain Res 1200:159–168.
   PubMed Web of Science ®Google Scholar
• Yatvin, M. B., Li, W., Meredith, M. J., Shenoy, M. A. (1999). Improved uptake and retention of lipophilic prodrug to improve treatment of HIV. Adv Drug Deliv Rev 39(1–3):165–182.
   PubMedGoogle Scholar
• Ying, X., Wen, H., Lu, W., Du, J., Guo, J., Tian, W., et al. (2010). Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. J Contr Rel 141:183–192.
   PubMed Web of Science ®Google Scholar